Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines

New Jersey Community Capital Supports Growth of Newark Community Health Centers

Inmar Intelligence Partners with Deterra® to Expand Safe Medication Deactivation and Disposal

Cycle for Clean Air and Healthy Lungs: American Lung Association to Host Five Iconic Bike Treks in 2026

Remodel Health posts record growth in 2025, expands leadership team

Gut Health Supplement Market to Reach US$ 29.1 Billion by 2033 Expands Amid Rising Preventive Healthcare Adoption and Nutraceutical Innovation

LATAMHospital Food Services Market worth $1.80 billion by 2031 | MarketsandMarkets™

Para celebrar el hito de 100.000 pacientes tratados, Nordic Pharma Inc. (EE.UU.) amplía su oferta

TenderHeart Advances Value‑Based DME Models Aligned with CMS Priorities to Reduce Fraud, Waste, and Abuse

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026

Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma

Most In-Demand Hospitality Jobs in Texas Cities - OysterLink

National Menopause Foundation Expands Board Leadership

Choose Health Launches Comprehensive At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy and Mounjaro Users

NORDIC PHARMA, INC. ERREICHT MIT DER BEHANDLUNG VON 100.000 PATIENTEN EINEN WICHTIGEN MEILENSTEIN. (USA) ERWEITERT SEIN ANGEBOT UND ERHÖHT DEN BEDIENUNGSKOMFORT, INDEM ES SEINEN LIEFERUNGEN VON LACRIFILL® KANALIKULÄRES GEL ZUR BEHANDLUNG TROCKENER AUGEN BEILEGT

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

MARQUANT L'ÉTAPE IMPORTANTE DES 100 000 PATIENTS TRAITÉS, NORDIC PHARMA, INC. (U.S.) ÉLARGIT SON OFFRE ET AUGMENTE LA COMMODITÉ POUR LES PRESTATAIRES EN INCLUANT DES CANULES DANS SES LIVRAISONS DE GEL CANALICULAIRE LACRIFILL® POUR LE TRAITEMENT DES SYMPTÔMES DE LA SÉCHERESSE OCULAIRE.

Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)

Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting

Metro Health Care Costs Vary by More than Twofold Nationwide

Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg

RO OFFERS ELI LILLY'S FOUNDAYO™, THE NEWEST GLP-1 INNOVATION

Lodging Dynamics Launches Next-Generation Commercial Strategy with the Appointment of CCO Kristie Byrd

Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.

Avalon Healthcare Solutions Recognized as USA TODAY Top Workplace

West to Host First-Quarter 2026 Conference Call

Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026

GTCR Completes Acquisition of Zentiva, a Leading European Generics Pharmaceutical Company